It is well recognized that patients with diabetes mellitus (DM) are at risk for fatty liver disease.
In a study published in Gut, liver stiffness measurements (LSM) and liver fat was assessed in almost 1800 diabetics using Fibroscan with controlled attenuation parameter (CAP).
72.8% of patients had NAFLD (defined by an increased CAP) and 17.7% had elevated liver stiffness suggestive of advanced fibrosis.